FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

por Wang, De-shen, Wei, Xiao-li, Wang, Zhi-qiang, Lu, Yun-xin, Shi, Si-mei, Wang, Niu, Qiu, Miao-zhen, Wang, Feng-hua, Wang, Rong-jiao, Li, Yu-hong, Xu, Rui-hua
Publicado en Onco Targets Ther (2017)

Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer

por Qiu, Miao-Zhen, Shi, Si-Mei, Chen, Min, Wang, Jing, Wu, Qi-Nian, Sheng, Hui, Zhang, Hui-Zhong, Yun, Jing-Ping, Zhou, Zhi-Wei, Wang, Feng-Hua, Yang, Da-Jun, Xu, Rui-Hua
Publicado en J Cancer (2017)

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

por Qiu, Miao‐Zhen, Shi, Si‐Mei, Chen, Zhan‐Hong, Yu, Hong‐En, Sheng, Hui, Jin, Ying, Wang, De‐Shen, Wang, Feng‐Hua, Li, Yu‐Hong, Xie, Dan, Zhou, Zhi‐Wei, Yang, Da‐Jun, Xu, Rui‐Hua
Publicado en Cancer Med (2018)

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer

por Wang, Feng, He, Ming-Ming, Wang, Zi-Xian, Li, Su, Jin, Ying, Ren, Chao, Shi, Si-Mei, Bi, Bing-Tian, Chen, Shuang-Zhen, Lv, Zhi-Da, Hu, Jia-Jia, Wang, Zhi-Qiang, Wang, Feng-Hua, Wang, De-Shen, Li, Yu-Hong, Xu, Rui-Hua
Publicado en BMC Cancer (2019)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III...

por Wang, De‐shen, Wang, Zhi‐qiang, Chen, Gong, Peng, Jie‐wen, Wang, Wei, Deng, Yan‐hong, Wang, Feng‐hua, Zhang, Jian‐wei, Liang, Han‐lin, Feng, Fen, Xie, Chuan‐bo, Ren, Chao, Jin, Ying, Shi, Si‐mei, Fan, Wen‐hua, Lu, Zhen‐hai, Ding, Pei‐rong, Wang, Feng, Xu, Rui‐hua, Li, Yu‐hong
Publicado en Cancer Med (2019)